Publications

• Using High-sensitivity Sequencing for the Detection of Mutations in BTK and PLCγ2 Genes in Cellular and Cell-free DNA and Correlation with Progression in Patients Treated with BTK Inhibitors
  Oncotarget. Feb, 2017  |   Pubmed ID: 28212557
• Clonal Evolution Leading to Ibrutinib Resistance in Chronic Lymphocytic Leukemia
  Blood. Mar, 2017  |   Pubmed ID: 28049639
• Prevalence and Relative Proportions of CLL and Non-CLL Monoclonal B-cell Lymphocytosis Phenotypes in the Middle Eastern Population
  Hematology/oncology and Stem Cell Therapy. Mar, 2017  |   Pubmed ID: 27842210
• Resistance to Imatinib in Patients with Chronic Myelogenous Leukemia and the Splice Variant BCR-ABL1(35INS)
  Leukemia Research. Oct, 2016  |   Pubmed ID: 27658269
• Deep Sequencing of Cell-Free Peripheral Blood DNA As a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome
  Genetic Testing and Molecular Biomarkers. Jul, 2016  |   Pubmed ID: 27248906
• Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic Malignancies
  Biotechnology Research International. 2016  |   Pubmed ID: 27006832
• Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System
  Journal of Cancer. 2016  |   Pubmed ID: 26918043
• Synonymous Polymorphisms in HOXB13 As a Protective Factor for Prostate Cancer
  Journal of Cancer. 2015  |   Pubmed ID: 25874003
• Diagnostic and Prognostic Scoring System for Prostate Cancer Using Urine and Plasma Biomarkers
  Genetic Testing and Molecular Biomarkers. Mar, 2014  |   Pubmed ID: 24512523
• Correlations Between Cytogenetic and Molecular Monitoring Among Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Post Hoc Analyses of the Rationale and Insight for Gleevec High-Dose Therapy Study
  Archives of Pathology & Laboratory Medicine. Sep, 2014  |   Pubmed ID: 24308645
• Dysregulation of Ubiquitin-proteasome Pathway and Apolipoprotein A Metabolism in Sickle Cell Disease-related Pulmonary Arterial Hypertension
  Pulmonary Circulation. Dec, 2013  |   Pubmed ID: 25006400
• The T(9;11) Confers Good Prognosis in AML Patients Treated with Stem Cell Transplantation As Compared to Non-t(9;11) and Other Adverse-risk Abnormalities
  Hematology/oncology and Stem Cell Therapy. 2012  |   Pubmed ID: 23095795
• Plasma Ubiquitin-proteasome System Profile in Patients with Multiple Sclerosis: Correlation with Clinical Features, Neuroimaging, and Treatment with Interferon-beta-1b
  Neurological Research. Jul, 2012  |   Pubmed ID: 22709658
• Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level Through Computational Modeling
  PloS One. 2011  |   Pubmed ID: 21858098
• Trainable Immunohistochemical HER2/neu Image Analysis: a Multisite Performance Study Using 260 Breast Tissue Specimens
  Archives of Pathology & Laboratory Medicine. Jul, 2011  |   Pubmed ID: 21732780
• Fluorescence in Situ Hybridization and K-ras Analyses Improve Diagnostic Yield of Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Masses
  Pancreas. Oct, 2011  |   Pubmed ID: 21705950
• Tanespimycin and Bortezomib Combination Treatment in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Results of a Phase 1/2 Study
  British Journal of Haematology. Jun, 2011  |   Pubmed ID: 21534941
• Reading Immunohistochemical Slides on a Computer Monitor--a Multisite Performance Study Using 180 HER2-stained Breast Carcinomas
  Applied Immunohistochemistry & Molecular Morphology : AIMM. May, 2011  |   Pubmed ID: 21475038
• Ubiquitin-proteasome Profiling for Enhanced Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease
  Journal of Gastroenterology and Hepatology. Apr, 2011  |   Pubmed ID: 21418304
• Exon Scanning by Reverse Transcriptase-polymerase Chain Reaction for Detection of Known and Novel EML4-ALK Fusion Variants in Non-small Cell Lung Cancer
  Cancer Genetics. Jan, 2011  |   Pubmed ID: 21356191
• MPL Mutation Profile in JAK2 Mutation-negative Patients with Myeloproliferative Disorders
  Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Mar, 2011  |   Pubmed ID: 21326037
• Circulating MicroRNAs As Biomarkers for Hepatocellular Carcinoma
  Journal of Clinical Gastroenterology. Apr, 2011  |   Pubmed ID: 21278583
• Ubiquitin-proteasome System Profiling in Acute Leukemias and Its Clinical Relevance
  Leukemia Research. Apr, 2011  |   Pubmed ID: 20951430
• Significant Association Between Polymorphism of the Erythropoietin Gene Promoter and Myelodysplastic Syndrome
  BMC Medical Genetics. Nov, 2010  |   Pubmed ID: 21078205
• Somatic Mutations of Signaling Genes in Non-small-cell Lung Cancer
  Cancer Genetics and Cytogenetics. Nov, 2010  |   Pubmed ID: 20951313
• Long-term Follow-up of Monoclonal B-cell Lymphocytosis Detected in Environmental Health Studies
  Cytometry. Part B, Clinical Cytometry. 2010  |   Pubmed ID: 20839341
• JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
  PloS One. Aug, 2010  |   Pubmed ID: 20730051
• Tanespimycin with Bortezomib: Activity in Relapsed/refractory Patients with Multiple Myeloma
  British Journal of Haematology. Aug, 2010  |   Pubmed ID: 20618338
• Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-escalation Study
  British Journal of Haematology. Aug, 2010  |   Pubmed ID: 20618337
• Quantification of Intracellular Proteins and Monitoring Therapy Using Flow Cytometry
  Current Drug Targets. Aug, 2010  |   Pubmed ID: 20426764
• Circulating CD33 and Its Clinical Value in Acute Leukemia
  Experimental Hematology. Jun, 2010  |   Pubmed ID: 20362641
• Circulating Ki-67 Index in Plasma As a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia
  Leukemia Research. Oct, 2010  |   Pubmed ID: 20362333
• Single-agent Laromustine, a Novel Alkylating Agent, Has Significant Activity in Older Patients with Previously Untreated Poor-risk Acute Myeloid Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2010  |   Pubmed ID: 20026800
• Circulating CD52 and CD20 Levels at End of Treatment Predict for Progression and Survival in Patients with Chronic Lymphocytic Leukaemia Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR)
  British Journal of Haematology. Feb, 2010  |   Pubmed ID: 19895616
• Clinical Correlation of Circulating Heat Shock Protein 70 in Acute Leukemia
  Leukemia Research. May, 2010  |   Pubmed ID: 19800118
• Circulating Ki-67 Protein in Plasma As a Biomarker and Prognostic Indicator of Acute Lymphoblastic Leukemia
  Leukemia Research. Feb, 2010  |   Pubmed ID: 19679351
• Evidence of Serum Immunoglobulin Abnormalities Up to 9.8 Years Before Diagnosis of Chronic Lymphocytic Leukemia: a Prospective Study
  Blood. Dec, 2009  |   Pubmed ID: 19828698
• Structural Effects of Clinically Observed Mutations in JAK2 Exons 13-15: Comparison with V617F and Exon 12 Mutations
  BMC Structural Biology. Sep, 2009  |   Pubmed ID: 19744331
• High-dose Imatinib in Newly Diagnosed Chronic-phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2009  |   Pubmed ID: 19720924
• Phase 3 Randomized, Placebo-controlled, Double-blind Study of High-dose Continuous Infusion Cytarabine Alone or with Laromustine (VNP40101M) in Patients with Acute Myeloid Leukemia in First Relapse
  Blood. Nov, 2009  |   Pubmed ID: 19710500
• Acute Lymphoblastic Leukemia with Burkitt-like Morphologic Features and High Myeloperoxidase Activity
  American Journal of Clinical Pathology. Aug, 2009  |   Pubmed ID: 19605811
• Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndromes: the Alternative Dosing for Outpatient Treatment (ADOPT) Trial
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2009  |   Pubmed ID: 19528372
• Basis for Resistance to Imatinib in 16 BCR-ABL Mutants As Determined Using Molecular Dynamics
  Recent Patents on Anti-cancer Drug Discovery. Jun, 2009  |   Pubmed ID: 19519539
• Proteasome Enzymatic Activities in Plasma As Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-stage Myelodysplastic Syndrome
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2009  |   Pubmed ID: 19458051
• Proteomics-based Prediction of Clinical Response in Acute Myeloid Leukemia
  Experimental Hematology. Jul, 2009  |   Pubmed ID: 19422784
• Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells
  Cancer Research. May, 2009  |   Pubmed ID: 19383925
• BCR-ABL Truncation Due to Premature Translation Termination As a Mechanism of Resistance to Kinase Inhibitors
  Acta Haematologica. 2009  |   Pubmed ID: 19332983
• Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications
  Cancer Biomarkers : Section A of Disease Markers. 2009  |   Pubmed ID: 19242062
• K-ras Mutations and Cetuximab in Colorectal Cancer
  The New England Journal of Medicine. Feb, 2009  |   Pubmed ID: 19238675
• B-cell Clones As Early Markers for Chronic Lymphocytic Leukemia
  The New England Journal of Medicine. Feb, 2009  |   Pubmed ID: 19213679
• Mechanisms of Constitutive Activation of Janus Kinase 2-V617F Revealed at the Atomic Level Through Molecular Dynamics Simulations
  Cancer. Apr, 2009  |   Pubmed ID: 19195039
• Plasma-based Detection of Clonality in Lymphoid Malignancies
  European Journal of Haematology. Jun, 2009  |   Pubmed ID: 19187275
• Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
  The Journal of Molecular Diagnostics : JMD. Jan, 2009  |   Pubmed ID: 19074595
• Circulating Heat Shock Protein 70 and Progression in Patients with Chronic Myeloid Leukemia
  Leukemia Research. Feb, 2009  |   Pubmed ID: 18715642
• BCR-ABL Alternative Splicing As a Common Mechanism for Imatinib Resistance: Evidence from Molecular Dynamics Simulations
  Molecular Cancer Therapeutics. Dec, 2008  |   Pubmed ID: 19056677
• Liquid-based Fluorescence in Situ Hybridization Assay for Detection of ERBB2 Gene Amplification in Patients with Breast Cancer
  Clinical Chemistry. Nov, 2008  |   Pubmed ID: 18787015
• Toward the Identification of Mesenchymal Stem Cells in Bone Marrow and Peripheral Blood for Bone Regeneration
  Implant Dentistry. Sep, 2008  |   Pubmed ID: 18784524
• The Prognostic Significance of Cytokine Levels in Newly Diagnosed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndromes
  Cancer. Oct, 2008  |   Pubmed ID: 18683214
• A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2008  |   Pubmed ID: 18451242
• Higher Detection Rate of JAK2 Mutation Using Plasma
  Blood. Apr, 2008  |   Pubmed ID: 18362222
• Molecular Basis Explanation for Imatinib Resistance of BCR-ABL Due to T315I and P-loop Mutations from Molecular Dynamics Simulations
  Cancer. Apr, 2008  |   Pubmed ID: 18338744
• Enzymatic Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Lymphocytic Leukemia
  Cancer. Mar, 2008  |   Pubmed ID: 18224667
• An Immunological Method for the Detection of BCR-ABL Fusion Protein and Monitoring Its Activation
  Leukemia Research. Jun, 2008  |   Pubmed ID: 18155764
• Phosphorylation Levels of BCR-ABL, CrkL, AKT and STAT5 in Imatinib-resistant Chronic Myeloid Leukemia Cells Implicate Alternative Pathway Usage As a Survival Strategy
  Leukemia Research. Apr, 2008  |   Pubmed ID: 17900686
• Detection of Chromosome Translocations by Bead-based Flow Cytometry
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605085
• Measuring Humanized Antibodies in Plasma of Patients Treated with Antibody-based Therapy Using Bead-based Flow Cytometry: the Story of Alemtuzumab
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605084
• Cell-free Bead-based Detection of Total and Phosphorylated Proteins in Plasma and Cell Lysates: Detection of FLT3
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605083
• Monitoring Cell Signaling Pathways by Quantitative Flow Cytometry
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605080
• Quantification of Surface Antigens and Quantitative Flow Cytometry
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605078
• He Use of the Antibodies in the Diagnosis of Leukemia and Lymphoma by Flow Cytometry
  Methods in Molecular Biology (Clifton, N.J.). 2007  |   Pubmed ID: 18605077
• A Potential Role for HSP90 Inhibitors in the Treatment of JAK2 Mutant-positive Diseases As Demonstrated Using Quantitative Flow Cytometry
  Leukemia & Lymphoma. Nov, 2007  |   Pubmed ID: 17926180
• Plasma-based Testing As a New Paradigm for Clinical Testing in Hematologic Diseases
  Expert Review of Molecular Diagnostics. Sep, 2007  |   Pubmed ID: 17892367
• Bi-clonal Disease in Patients with Chronic Lymphocytic Leukaemia As Detected by Analysing IGHV Mutation Status
  British Journal of Haematology. Nov, 2007  |   Pubmed ID: 17868045
• PTK787/ZK 222584, a Small Molecule Tyrosine Kinase Receptor Inhibitor of Vascular Endothelial Growth Factor (VEGF), Has Modest Activity in Myelofibrosis with Myeloid Metaplasia
  Leukemia Research. Jul, 2007  |   Pubmed ID: 17560285
• Plasma RNA As an Alternative to Cells for Monitoring Molecular Response in Patients with Chronic Myeloid Leukemia
  Haematologica. Feb, 2007  |   Pubmed ID: 17296565
• The Haematopoietic Cell Transplantation Comorbidity Index Score is Predictive of Early Death and Survival in Patients over 60 Years of Age Receiving Induction Therapy for Acute Myeloid Leukaemia
  British Journal of Haematology. Feb, 2007  |   Pubmed ID: 17223919
• Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older with Previously Untreated Acute Myeloid Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jan, 2007  |   Pubmed ID: 17146105
• Clinical Relevance of Soluble HLA-I and Beta2-microglobulin Levels in Non-Hodgkin's Lymphoma and Hodgkin's Disease
  Leukemia Research. Feb, 2007  |   Pubmed ID: 16545870
• Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2006  |   Pubmed ID: 16951235
• A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2006  |   Pubmed ID: 16899611
• Validation of the European Prognostic Index for Younger Adult Patients with Acute Myeloid Leukaemia in First Relapse
  British Journal of Haematology. Jul, 2006  |   Pubmed ID: 16803568
• Nilotinib in Imatinib-resistant CML and Philadelphia Chromosome-positive ALL
  The New England Journal of Medicine. Jun, 2006  |   Pubmed ID: 16775235
• Circulating Levels and Clinical Significance of Soluble CD40 in Patients with Hematologic Malignancies
  Cancer. May, 2006  |   Pubmed ID: 16598754
• Thalidomide Therapy for Myelofibrosis with Myeloid Metaplasia
  Cancer. May, 2006  |   Pubmed ID: 16583431
• A Phase II Study of Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients with Very High Risk Relapsed Acute Myeloid Leukemia
  Leukemia Research. Dec, 2006  |   Pubmed ID: 16574225
• Plasma Thrombopoietin Compared with Immunoglobulin Heavy-chain Mutation Status As a Predictor of Survival in Chronic Lymphocytic Leukemia
  Blood. Aug, 2006  |   Pubmed ID: 16551975
• Decitabine Improves Patient Outcomes in Myelodysplastic Syndromes: Results of a Phase III Randomized Study
  Cancer. Apr, 2006  |   Pubmed ID: 16532500
• Proteomic-based Prediction of Clinical Behavior in Adult Acute Lymphoblastic Leukemia
  Cancer. Apr, 2006  |   Pubmed ID: 16518825
• Monoclonal Antibodies in the Treatment of Leukemia
  Current Molecular Medicine. Nov, 2005  |   Pubmed ID: 16305492
• Mammalian Target of Rapamycin As a Therapeutic Target in Leukemia
  Current Molecular Medicine. Nov, 2005  |   Pubmed ID: 16305491
• Phase I Study of Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, Combined with Cytarabine in Patients with Refractory Leukemia
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2005  |   Pubmed ID: 16278404
• Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2005  |   Pubmed ID: 16166440
• Angiogenic Factors May Have a Different Prognostic Role in Adult Acute Lymphoblastic Leukemia
  Blood. Dec, 2005  |   Pubmed ID: 16123221
• Cognitive Impairment, Fatigue, and Cytokine Levels in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  Cancer. Aug, 2005  |   Pubmed ID: 15973668
• Adaptive Randomized Study of Idarubicin and Cytarabine Alone or with Interleukin-11 As Induction Therapy in Patients Aged 50 or Above with Acute Myeloid Leukemia or High-risk Myelodysplastic Syndromes
  Leukemia Research. Jun, 2005  |   Pubmed ID: 15863204
• Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2005  |   Pubmed ID: 15767648
• Chemoimmunotherapy with Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2005  |   Pubmed ID: 15767647
• Alemtuzumab: Validation of a Sensitive and Simple Enzyme-linked Immunosorbent Assay
  Leukemia Research. Dec, 2004  |   Pubmed ID: 15475065
• Free Circulating Soluble CD52 As a Tumor Marker in Chronic Lymphocytic Leukemia and Its Implication in Therapy with Anti-CD52 Antibodies
  Cancer. Sep, 2004  |   Pubmed ID: 15329909
• Telomerase Activity is Not a Prognostic Factor in Chronic Lymphocytic Leukemia
  Leukemia Research. Jul, 2004  |   Pubmed ID: 15158092
• Effects of SU5416, a Small Molecule Tyrosine Kinase Receptor Inhibitor, on FLT3 Expression and Phosphorylation in Patients with Refractory Acute Myeloid Leukemia
  Leukemia Research. Jul, 2004  |   Pubmed ID: 15158089
• The Clinical Significance of Large Cells in Bone Marrow in Patients with Chronic Lymphocytic Leukemia
  Cancer. May, 2004  |   Pubmed ID: 15139060
• Clinical Relevance of Circulating Angiogenic Factors in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  Leukemia Research. Jun, 2004  |   Pubmed ID: 15120936
• Soluble Vascular Endothelial Growth Factor Receptor 1, and Not Receptor 2, is an Independent Prognostic Factor in Acute Myeloid Leukemia and Myelodysplastic Syndromes
  Cancer. May, 2004  |   Pubmed ID: 15112269
• C-kit Receptor Expression in Acute Leukemias-association with Patient and Disease Characteristics and with Outcome
  Leukemia Research. Apr, 2004  |   Pubmed ID: 15109537
• Myelodysplastic Syndrome: from Morphology to Biology
  Current Hematology Reports. May, 2004  |   Pubmed ID: 15087062
• Phase II Study of R115777, a Farnesyl Transferase Inhibitor, in Myelodysplastic Syndrome
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2004  |   Pubmed ID: 15051776
• Phase I and Pharmacokinetic Study of a Low-clearance, Unilamellar Liposomal Formulation of Lurtotecan, a Topoisomerase 1 Inhibitor, in Patients with Advanced Leukemia
  Cancer. Apr, 2004  |   Pubmed ID: 15042679
• Thalidomide for Patients with Recurrent Lymphoma
  Cancer. Mar, 2004  |   Pubmed ID: 15022285
• Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
  Cancer Research. Jan, 2004  |   Pubmed ID: 14744784
• Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2004  |   Pubmed ID: 14734456
• Bovine Serum Albumin in the Preparation of Peripheral Blood Smears
  Cytometry. Part B, Clinical Cytometry. Jan, 2004  |   Pubmed ID: 14696064
• Intrinsic Oxidative Stress in Cancer Cells: a Biochemical Basis for Therapeutic Selectivity
  Cancer Chemotherapy and Pharmacology. Mar, 2004  |   Pubmed ID: 14610616
• Relative Increase in Leukemia-specific DNA in Peripheral Blood Plasma from Patients with Acute Myeloid Leukemia and Myelodysplasia
  Blood. Apr, 2004  |   Pubmed ID: 14576069
• Alemtuzumab As Treatment for Residual Disease After Chemotherapy in Patients with Chronic Lymphocytic Leukemia
  Cancer. Dec, 2003  |   Pubmed ID: 14669286
• Circulating CD20 and CD52 in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
  British Journal of Haematology. Dec, 2003  |   Pubmed ID: 14632776
• Single Agent Thalidomide in Patients with Relapsed or Refractory Acute Myeloid Leukaemia
  British Journal of Haematology. Nov, 2003  |   Pubmed ID: 14617002
• The Clinical Significance of Soluble CD86 Levels in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
  Cancer. Oct, 2003  |   Pubmed ID: 14534885
• Molecular Differences Between Small and Large Cells in Patients with Chronic Lymphocytic Leukemia
  European Journal of Haematology. Oct, 2003  |   Pubmed ID: 12950231
• Use of Plasma DNA in Detection of Loss of Heterozygosity in Patients with Multiple Myeloma
  European Journal of Haematology. Sep, 2003  |   Pubmed ID: 12930317
• Phase II Study of Troxacitabine, a Novel Dioxolane Nucleoside Analog, in Patients with Untreated or Imatinib Mesylate-resistant Chronic Myelogenous Leukemia in Blastic Phase
  Leukemia Research. Dec, 2003  |   Pubmed ID: 12921945
• Transient Down-modulation of CD20 by Rituximab in Patients with Chronic Lymphocytic Leukemia
  Blood. Nov, 2003  |   Pubmed ID: 12893761
• ATM Mutations and Protein Expression Are Not Associated with Familial B-CLL Cases
  Leukemia Research. Oct, 2003  |   Pubmed ID: 12860021
• Gemtuzumab Ozogamicin, Fludarabine, Cytarabine and Cyclosporine Combination Regimen in Patients with CD33+ Primary Resistant or Relapsed Acute Myeloid Leukemia
  Leukemia Research. Oct, 2003  |   Pubmed ID: 12860008
• Anagrelide and Imatinib Mesylate Combination Therapy in Patients with Chronic Myeloproliferative Disorders
  Cancer Chemotherapy and Pharmacology. Sep, 2003  |   Pubmed ID: 12783207
• Results of Imatinib Mesylate Therapy in Patients with Refractory or Recurrent Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, and Myeloproliferative Disorders
  Cancer. Jun, 2003  |   Pubmed ID: 12767088
• A Prognostic Model for Survival in Chronic Lymphocytic Leukaemia Based on P53 Expression
  British Journal of Haematology. May, 2003  |   Pubmed ID: 12752098
• In Vitro Activity of Dimethylarsinic Acid Against Human Leukemia and Multiple Myeloma Cell Lines
  Cancer Chemotherapy and Pharmacology. May, 2003  |   Pubmed ID: 12736761
• Increased Apoptosis in Bone Marrow B Lymphocytes but Not T Lymphocytes in Myelodysplastic Syndrome
  Blood. Sep, 2003  |   Pubmed ID: 12730116
• Telomerase Activity is Prognostic in Pediatric Patients with Acute Myeloid Leukemia: Comparison with Adult Acute Myeloid Leukemia
  Cancer. May, 2003  |   Pubmed ID: 12712473
• Vascularity, Angiogenesis and Angiogenic Factors in Leukemias and Myelodysplastic Syndromes
  Leukemia & Lymphoma. Feb, 2003  |   Pubmed ID: 12688336
• Clinical Relevance of VEGF Receptors 1 and 2 in Patients with Chronic Myelogenous Leukemia
  Leukemia Research. Jul, 2003  |   Pubmed ID: 12681367
• Phase II Study of SU5416--a Small-molecule, Vascular Endothelial Growth Factor Tyrosine-kinase Receptor Inhibitor--in Patients with Refractory Myeloproliferative Diseases
  Cancer. Apr, 2003  |   Pubmed ID: 12673719
• Clinical Relevance of the Expression of the CD31 Ligand for CD38 in Patients with B-cell Chronic Lymphocytic Leukemia
  Cancer. Apr, 2003  |   Pubmed ID: 12673718
• Fractionated Cyclophosphamide, Vincristine, Liposomal Daunorubicin, and Dexamethasone Plus Rituximab and Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) Alternating with Methotrexate and Cytarabine Plus Rituximab and GM-CSF in Patients with Richter Syndrome or Fludarabine-refractory Chronic Lymphocytic Leukemia
  Cancer. Apr, 2003  |   Pubmed ID: 12655528
• SU5416, a Small Molecule Tyrosine Kinase Receptor Inhibitor, Has Biologic Activity in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
  Blood. Aug, 2003  |   Pubmed ID: 12649163
• Gemtuzumab, Fludarabine, Cytarabine, and Cyclosporine in Patients with Newly Diagnosed Acute Myelogenous Leukemia or High-risk Myelodysplastic Syndromes
  Cancer. Mar, 2003  |   Pubmed ID: 12627513
• Pilot Study of Recombinant Human Soluble Tumor Necrosis Factor (TNF) Receptor (p75) Fusion Protein (TNFR:Fc; Enbrel) in Patients with Refractory Multiple Myeloma: Increase in Plasma TNF Alpha Levels During Treatment
  Leukemia Research. May, 2003  |   Pubmed ID: 12620287
• Increased Telomerase Activity is Associated with Shorter Survival in Patients with Chronic Phase Chronic Myeloid Leukemia
  Cancer. Mar, 2003  |   Pubmed ID: 12599232
• A Randomized Trial of Liposomal Daunorubicin and Cytarabine Versus Liposomal Daunorubicin and Topotecan with or Without Thalidomide As Initial Therapy for Patients with Poor Prognosis Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  Cancer. Mar, 2003  |   Pubmed ID: 12599230
• Plasma Interleukin 8 Level Predicts for Survival in Chronic Lymphocytic Leukaemia
  British Journal of Haematology. Feb, 2003  |   Pubmed ID: 12580959
• Aberrant DNA Methylation in Pediatric Patients with Acute Lymphocytic Leukemia
  Cancer. Feb, 2003  |   Pubmed ID: 12548613
• Presence of Restricted Killer Immunoglobulin-like Receptor Repertoire and Monoclonal T-cell Receptor Gamma Rearrangement As Evidence of Mixed NK/T-cell Differentiation in a Subset of Sinonasal Lymphomas
  Laboratory Investigation; a Journal of Technical Methods and Pathology. Jan, 2003  |   Pubmed ID: 12533686
• The Prognostic Significance of Bone Marrow Levels of Neurofibromatosis-1 Protein and Ras Oncogene Mutations in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
  Cancer. Jan, 2003  |   Pubmed ID: 12518368
• Circulating CD20 is Detectable in the Plasma of Patients with Chronic Lymphocytic Leukemia and is of Prognostic Significance
  Blood. Apr, 2003  |   Pubmed ID: 12446458
• Efficacy of the Farnesyl Transferase Inhibitor R115777 in Chronic Myeloid Leukemia and Other Hematologic Malignancies
  Blood. Mar, 2003  |   Pubmed ID: 12411300
• Emerging Information on the Use of Rituximab in Chronic Lymphocytic Leukemia
  Seminars in Oncology. Feb, 2002  |   Pubmed ID: 28140094
• Association of Cancer-related Symptoms with Physiological Parameters
  Journal of Pain and Symptom Management. Oct, 2002  |   Pubmed ID: 12505202
• Chronic Lymphocytic Leukemia with T(14;18) and Trisomy 12
  Archives of Pathology & Laboratory Medicine. Dec, 2002  |   Pubmed ID: 12456221
• Plasma Vascular Endothelial Growth Factor Levels Have Prognostic Significance in Patients with Acute Myeloid Leukemia but Not in Patients with Myelodysplastic Syndromes
  Cancer. Nov, 2002  |   Pubmed ID: 12404286
• Differences in CD33 Intensity Between Various Myeloid Neoplasms
  American Journal of Clinical Pathology. Oct, 2002  |   Pubmed ID: 12375643
• Characteristics and Outcome of Patients with Philadelphia Chromosome Negative, Bcr/abl Negative Chronic Myelogenous Leukemia
  Cancer. Oct, 2002  |   Pubmed ID: 12365015
• Bone Marrow Cyclooxygenase-2 Levels Are Elevated in Chronic-phase Chronic Myeloid Leukaemia and Are Associated with Reduced Survival
  British Journal of Haematology. Oct, 2002  |   Pubmed ID: 12358901
• Epidemiology, Molecular Mycology, and Environmental Sources of Fusarium Infection in Patients with Cancer
  Infection Control and Hospital Epidemiology. Sep, 2002  |   Pubmed ID: 12269452
• Prognostic Value of Plasma Interleukin-6 Levels in Patients with Chronic Lymphocytic Leukemia
  Cancer. Sep, 2002  |   Pubmed ID: 12209693
• Recombinant Human Soluble Tumor Necrosis Factor (TNF) Receptor (p75) Fusion Protein Enbrel in Patients with Refractory Hematologic Malignancies
  Cancer Chemotherapy and Pharmacology. Sep, 2002  |   Pubmed ID: 12203106
• Less Apoptosis in Patients with 5q-syndrome Than in Patients with Refractory Anemia
  Leukemia Research. Oct, 2002  |   Pubmed ID: 12163050
• CXCR4 Expression is Associated with Survival in Familial Chronic Lymphocytic Leukemia, but CD38 Expression is Not
  Blood. Aug, 2002  |   Pubmed ID: 12150154
• The Clinical Significance of Tumor Necrosis Factor-alpha Plasma Level in Patients Having Chronic Lymphocytic Leukemia
  Blood. Aug, 2002  |   Pubmed ID: 12149200
• Myelodysplastic Syndrome is Not Merely "preleukemia"
  Blood. Aug, 2002  |   Pubmed ID: 12130488
• Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-phase Myeloid Leukemia After Failure of Interferon-alpha: Follow-up Results
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2002  |   Pubmed ID: 12114418
• Clinical Relevance of Vascular Endothelial Growth Factor Receptors 1 and 2 in Acute Myeloid Leukaemia and Myelodysplastic Syndrome
  British Journal of Haematology. Jul, 2002  |   Pubmed ID: 12100142
• Proliferation and Apoptosis in Acute and Chronic Leukemias and Myelodysplastic Syndrome
  Leukemia Research. Jun, 2002  |   Pubmed ID: 12007503
• Therapeutic Role of Alemtuzumab (Campath-1H) in Patients Who Have Failed Fludarabine: Results of a Large International Study
  Blood. May, 2002  |   Pubmed ID: 11986207
• Imatinib Mesylate (STI571) Therapy for Philadelphia Chromosome-positive Chronic Myelogenous Leukemia in Blast Phase
  Blood. May, 2002  |   Pubmed ID: 11986206
• Diagnosis of Invasive Pulmonary Aspergillosis Using Polymerase Chain Reaction-based Detection of Aspergillus in BAL
  Chest. Apr, 2002  |   Pubmed ID: 11948049
• The Clinical and Diagnostic Relevance of CD23 Expression in the Chronic Lymphoproliferative Disease
  Cancer. Mar, 2002  |   Pubmed ID: 11920534
• Prognostic Significance of Tie-1 Protein Expression in Patients with Early Chronic Phase Chronic Myeloid Leukemia
  Cancer. Mar, 2002  |   Pubmed ID: 11920509
• Polymerase Chain Reaction on Blood for the Diagnosis of Invasive Pulmonary Aspergillosis in Cancer Patients
  Cancer. Feb, 2002  |   Pubmed ID: 11920473
• Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-blood Stem Cells
  The New England Journal of Medicine. Mar, 2002  |   Pubmed ID: 11882729
• Prognostic Significance of Cellular Vascular Endothelial Growth Factor Expression in Chronic Phase Chronic Myeloid Leukemia
  Blood. Mar, 2002  |   Pubmed ID: 11877311
• Emerging Information on the Use of Rituximab in Chronic Lymphocytic Leukemia
  Seminars in Oncology. Feb, 2002  |   Pubmed ID: 11842391
• Comparison Between Pediatric Acute Myeloid Leukemia (AML) and Adult AML in VEGF and KDR (VEGF-R2) Protein Levels
  Leukemia Research. Apr, 2002  |   Pubmed ID: 11839384
• Clinical Significance of Plasma Endostatin in Acute Myeloid Leukemia/myelodysplastic Syndrome
  Cancer. Jan, 2002  |   Pubmed ID: 11815955
• Prognostic Factors and Scoring Systems in Chronic Myelomonocytic Leukemia: a Retrospective Analysis of 213 Patients
  Blood. Feb, 2002  |   Pubmed ID: 11806985